Standard salvage therapy

OTHER2 trials

Sponsors

Stefan Carlsson, Yonsei University

Conditions

Prostate CancerRecurrent Epithelial Ovarian Cancer

Phase 3

Comparing Salvage Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer

RecruitingNCT04794777

Stefan CarlssonProstate Cancer

Start: 2018-10-30End: 2027-10-30Target: 450Updated: 2025-03-20

Unknown Phase

Salvage Systemic Therapy With or Without Stereotactic Ablative Radiotherapy for Recurrent Ovarian Cancer

RecruitingNCT05444270

Yonsei UniversityRecurrent Epithelial Ovarian Cancer

Start: 2022-10-26End: 2026-12-31Target: 270Updated: 2023-11-24

Related Papers

Radiotherapy quality assurance program of ongoing clinical trial using stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC): a dummy run study of a prospective, randomized, multicenter phase III trial (KGOG 3064/KROG 2204)

BMC Cancer2025-08-18

Study protocol for prospective multi-institutional phase III trial of standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC)

BMC Cancer2023-10-204 citations

PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial

BMC Cancer2022-03-0820 citations